DOI: 10.1182/blood.v89.6.1978. Isolation of Epstein-Barr Virus (EBV)-Specific Cytotoxic T Lymphocytes That Lyse Reed-Sternberg Cells: Implications for Immune-Mediated Therapy of EBV+ Hodgkin's Disease

Isolation of Epstein-Barr Virus (EBV)-Specific Cytotoxic T Lymphocytes That Lyse Reed-Sternberg Cells: Implications for Immune-Mediated Therapy of EBV+ Hodgkin's Disease

10.1182/blood.v89.6.1978

Crossref journal-article

American Society of Hematology

Blood (234)

Abstract

AbstractA subset of Hodgkin's disease (HD) patients have detectable Epstein-Barr virus (EBV) genomes in the malignant Reed-Sternberg (R-S) cells. R-S cells express only a limited set of latent EBV proteins, but only LMP1 and LMP2 can potentially elicit a CD8+ cytotoxic T-lymphocyte (CTL) response. We have evaluated if either of these proteins could be used as targets for specific adoptive T-cell therapy for EBV-positive (EBV+) HD. The success of this strategy requires that R-S cells are susceptible to lysis by CD8+ CTL, and that CTL specific for LMP1 and LMP2 can be detected and potentially amplified in HD patients. Antigen presentation and CTL sensitivity was evaluated with an in vitro maintained, phenotypically representative R-S cell line, HDLM-2. The R-S cells were able to process and present viral proteins, and to be efficiently lysed by specific CTL in a Class I–restricted manner. Since CTL responses to LMP1 and LMP2 do not represent the dominant responses to EBV, we examined if CTL clones specific for these proteins could be isolated despite the presence of weak or nondetectable responses in polyclonal T-cell lines. LMP-specific clones were generated from individuals either by cloning from the polyclonal EBV-reactive T-cell lines or by direct stimulation of peripheral blood mononuclear cells (PBMC) with cells expressing LMP1 or LMP2 as the only EBV protein. Our ability to isolate CTL specific for LMP proteins from individuals with HD and the sensitivity of R-S cells for CTL-mediated lysis suggest that the pursuit of specific adoptive immunotherapy represents a viable strategy for the subset of HD patients with EBV+ tumors.

Bibliography

Sing, A. P., Ambinder, R. F., Hong, D. J., Jensen, M., Batten, W., Petersdorf, E., & Greenberg, P. D. (1997). Isolation of Epstein-Barr Virus (EBV)-Specific Cytotoxic T Lymphocytes That Lyse Reed-Sternberg Cells: Implications for Immune-Mediated Therapy of EBV+ Hodgkinâs Disease. Blood, 89(6), 1978â1986.

Authors 7

Amy P. Sing (first)
Richard F. Ambinder (additional)
Doley J. Hong (additional)
Michael Jensen (additional)
Wendy Batten (additional)
Effie Petersdorf (additional)
Philip D. Greenberg (additional)

References 60 Referenced 90

{'key': '2019111909065557500_B1'}
10.1093/annonc/5.suppl_2.S17 / Ann Oncol / The treatment of Hodgkin's disease. by Rosenberg (1994)
10.1182/blood.V73.1.47.47 / Blood / Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC Lymphoma Group Controlled Clinical Trials: 1964-1987. by Tubiana (1989)
10.1200/JCO.1992.10.2.210 / J Clin Oncol / Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: The low probability for cure. by Longo (1992)
10.1016/0002-9343(91)90213-H / Am J Med / Autologous bone marrow transplantation for patients with relapsed Hodgkin's disease. by Armitage (1991)
10.1200/JCO.1990.8.3.527 / J Clin Oncol / High-dose cytotoxic therapy and bone marrow transplantation for relapsed Hodgkin's disease. by Jones (1990)
10.1126/science.1352912 / Science / Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. by Riddell (1992)
10.1056/NEJM199510193331603 / N Engl J Med / Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. by Walter (1995)
10.1126/science.1840703 / Science / A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. by van der Bruggen (1991)
10.1073/pnas.91.9.3515 / Proc Natl Acad Sci USA / Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. by Kawakami (1994)
{'key': '2019111909065557500_B11', 'first-page': '321', 'article-title': "Epidemiologic studies assessing the role of the Epstein-Barr virus in Hodgkin's disease.", 'volume': '60', 'author': 'Mueller', 'year': '1987', 'journal-title': 'Yale J Biol Med'} / Yale J Biol Med / Epidemiologic studies assessing the role of the Epstein-Barr virus in Hodgkin's disease. by Mueller (1987)
{'key': '2019111909065557500_B12', 'first-page': '701', 'article-title': "Epstein-Barr virus antibody in childhood Hodgkin's disease.", 'volume': '136', 'author': 'Shope', 'year': '1982', 'journal-title': 'Am J Dis Child'} / Am J Dis Child / Epstein-Barr virus antibody in childhood Hodgkin's disease. by Shope (1982)
10.1016/S0140-6736(81)92351-5 / Lancet / Presence of elevated antibody titres to Epstein-Barr virus before Hodgkin's disease. by Evans (1981)
10.1093/ajcp/91.1.1 / Am J Clin Pathol / A survey of Epstein-Barr virus DNA in lymphoid tissue. Frequent detection in Hodgkin's disease. by Staal (1989)
{'key': '2019111909065557500_B15', 'first-page': '1259', 'article-title': "Epstein-Barr virus and Hodgkin's disease. A correlative in situ hybridization and polymerase chain reaction study.", 'volume': '139', 'author': 'Weiss', 'year': '1991', 'journal-title': 'Am J Pathol'} / Am J Pathol / Epstein-Barr virus and Hodgkin's disease. A correlative in situ hybridization and polymerase chain reaction study. by Weiss (1991)
10.1002/ijc.2910460509 / Int J Cancer / Detection of EBV gene expression in Reed-Sternberg cells of Hodgkin's disease. by Wu (1990)
{'key': '2019111909065557500_B17', 'first-page': '86', 'article-title': "Epstein-Barr viral DNA in tissues of Hodgkin's disease.", 'volume': '129', 'author': 'Weiss', 'year': '1987', 'journal-title': 'Am J Pathol'} / Am J Pathol / Epstein-Barr viral DNA in tissues of Hodgkin's disease. by Weiss (1987)
10.1073/pnas.88.11.4766 / Proc Natl Acad Sci USA / Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells. by Herbst (1991)
10.1016/0140-6736(91)90943-J / Lancet / Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. by Pallesen (1991)
10.1084/jem.177.2.339 / J Exp Med / Epstein-Barr virus and Hodgkin's disease: Transcriptional analysis of virus latency in the malignant cells. by Deacon (1993)
10.1016/0092-8674(85)90256-9 / Cell / An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. by Wang (1985)
10.1128/JVI.69.4.2168-2174.1995 / J Virol / LMP-1 activates NF-kappa B by targeting the inhibitory molecule I kappa B alpha. by Herrero (1995)
{'key': '2019111909065557500_B23', 'first-page': '37', 'article-title': 'Absence of HLA class I expression by Reed-Sternberg cells.', 'volume': '145', 'author': 'Poppema', 'year': '1994', 'journal-title': 'Am J Pathol'} / Am J Pathol / Absence of HLA class I expression by Reed-Sternberg cells. by Poppema (1994)
10.1073/pnas.87.8.2906 / Proc Natl Acad Sci USA / Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses. by Murray (1990)
10.1084/jem.176.1.157 / J Exp Med / Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): Implications for the immune control of EBV-positive malignancies. by Murray (1992)
10.1182/blood.V86.4.1493.bloodjournal8641493 / Blood / Local suppression of Epstein-Barr virus (EBV)-specific cytotoxicity in biopsies of EBV-positive Hodgkin's disease. by Frisan (1995)
10.1038/375685a0 / Nature / Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. by Levitskaya (1995)
10.1007/978-3-642-83781-4_8 / Recent Results Cancer Res / Characterization of Hodgkin's disease derived cell line HDLM-2. by Drexler (1989)
10.1111/j.1399-0039.1994.tb02364.x / Tissue Antigens / Molecular diversity of the HLA-C locus in unrelated marrow transplantation. by Petersdorf (1994)
10.1111/j.1399-0039.1995.tb02482.x / Tissue Antigens / A comprehensive approach for typing the alleles of the HLA-B locus by automated sequencing. by Petersdorf (1995)
10.1111/j.1399-0039.1995.tb02470.x / Tissue Antigens / Nomenclature for factors of the HLA system, 1995. by Bodmer (1995)
{'key': '2019111909065557500_B32'}
10.4049/jimmunol.135.1.12 / J Immunol / Target specificity and cell surface structures involved in the human cytolytic T lymphocyte response to endothelial cells. by Clayberger (1985)
10.1101/SQB.1989.054.01.069 / Cold Spring Harb Symp Quant Biol / Variation in HLA expression on tumors: An escape from immune response. by Smith (1989)
10.1111/j.1749-6632.1993.tb43994.x / Ann NY Acad Sci / Tumor escape from immune response by variation in HLA expression and other mechanisms. by Bodmer (1993)
10.1084/jem.170.3.621 / J Exp Med / Suppression of class I human histocompatibility leukocyte antigen by c-myc is locus specific. by Versteeg (1989)
10.1084/jem.179.4.1205 / J Exp Med / T cell costimulation by B7/BB1 induces CD8 T cell–dependent tumor rejection: An important role of B7/BB1 in the induction, recruitment, and effector function of antitumor T cells. by Ramarathinam (1994)
10.1038/nm0296-216 / Nat Med / T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients. by Riddell (1996)
10.1016/S0140-6736(95)91150-2 / Lancet / Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus–related lymphoproliferation. by Rooney (1995)
10.1002/ijc.2910470205 / Int J Cancer / Expression of Epstein-Barr virus–encoded growth-transformation–associated proteins in lymphoproliferations of bone-marrow transplant recipients. by Gratama (1991)
10.1007/BF02634361 / In Vitro Cell Dev Biol Anim / Morphologic and immunophenotypic characterization of a cell line derived from liver tissue with Epstein-Barr virus associated post-transplant lymphoproliferative disease. by Randhawa (1994)
10.1084/jem.173.1.147 / J Exp Med / Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: Implications for the pathogenesis of EBV-positive lymphomas in man. by Rowe (1991)
{'key': '2019111909065557500_B43', 'first-page': '504', 'article-title': 'Expression of Epstein-Barr virus nuclear antigens in anti-IgM–stimulated B cells following recombinant vaccinia infection and their recognition by human cytotoxic T cells.', 'volume': '74', 'author': 'Khanna', 'year': '1991', 'journal-title': 'Immunology'} / Immunology / Expression of Epstein-Barr virus nuclear antigens in anti-IgM–stimulated B cells following recombinant vaccinia infection and their recognition by human cytotoxic T cells. by Khanna (1991)
{'key': '2019111909065557500_B44', 'first-page': '4', 'article-title': 'Potential antigenic targets on Epstein-Barr virus–associated tumours and the host response.', 'volume': '187', 'author': 'Moss', 'year': '1994', 'journal-title': 'Ciba Found Symp'} / Ciba Found Symp / Potential antigenic targets on Epstein-Barr virus–associated tumours and the host response. by Moss (1994)
{'key': '2019111909065557500_B45', 'first-page': '345', 'article-title': "Hodgkin's disease cell lines: A model for interleukin-1–independent accessory cell function [published erratum appears in Immunology 77:628, 1992].", 'volume': '77', 'author': 'McKenzie', 'year': '1992', 'journal-title': 'Immunology'} / Immunology / Hodgkin's disease cell lines: A model for interleukin-1–independent accessory cell function [published erratum appears in Immunology 77:628, 1992]. by McKenzie (1992)
10.1073/pnas.84.13.4567 / Proc Natl Acad Sci USA / Down-regulation of class I HLA antigens and of the Epstein-Barr virus–encoded latent membrane protein in Burkitt lymphoma lines. by Masucci (1987)
10.1093/intimm/4.11.1283 / Int Immunol / Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: In vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells. by Masucci (1992)
10.4049/jimmunol.150.11.5154 / J Immunol / EBV peptide epitope sensitization restores human cytotoxic T cell recognition of Burkitt's lymphoma cells. Evidence for a critical role for ICAM-2. by Khanna (1993)
10.1084/jem.167.6.1811 / J Exp Med / Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus–positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance. by Gregory (1988)
10.1182/blood.V87.9.3844.bloodjournal8793844 / Blood / Analysis of major histocompatibility complex class I expression on Reed-Sternberg cells in relation to the cytotoxic T-cell response in Epstein-Barr virus–positive and –negative Hodgkin's disease. by Oudejans (1996)
10.1016/0046-8177(93)90008-5 / Hum Pathol / Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin's disease and non-Hodgkin's lymphomas arising in patients without overt pre-existing immunodeficiency. by Kanavaros (1993)
10.1016/B978-0-12-364933-1.50013-8 / Int Rev Exp Pathol / Hodgkin's disease: Analysis of cell line data. by von-Kalle (1992)
10.1084/jem.177.2.265 / J Exp Med / Identification of human cancers deficient in antigen processing. by Restifo (1993)
10.1007/BF02918734 / Surv Immunol Res / Tumor growth and evasion of immune destruction: UV-induced tumors as a model. by Mullen (1985)
10.1084/jem.178.3.933 / J Exp Med / A tumor escape variant that has lost one major histocompatibility complex class I restriction element induces specific CD8+ T cells to an antigen that no longer serves as a target. by Seung (1993)
10.1126/science.1465616 / Science / Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. by Mizoguchi (1992)
10.1182/blood.V88.1.236.236 / Blood / T cells from patients with Hodgkin's disease have a defective T-cell receptor zeta chain expression that is reversible by T-cell stimulation with CD3 and CD28. by Renner (1996)
{'key': '2019111909065557500_B58', 'first-page': '1327', 'article-title': 'Alterations in T cell receptor and signal transduction molecules in melanoma patients.', 'volume': '1', 'author': 'Zea', 'year': '1995', 'journal-title': 'Clin Cancer Res'} / Clin Cancer Res / Alterations in T cell receptor and signal transduction molecules in melanoma patients. by Zea (1995)
10.1182/blood.V87.7.2918.bloodjournal8772918 / Blood / Frequent expression of interleukin-10 by Epstein-Barr virus–harboring tumor cells of Hodgkin's disease. by Herbst (1996)
10.4049/jimmunol.129.4.1770 / J Immunol / Depressed T cell proliferative responses in Hodgkin's disease: Role of monocyte-mediated suppression via prostaglandins and hydrogen peroxide. by Fisher (1982)

Dates

Type	When
Created	5 years, 10 months ago (Oct. 12, 2019, 3:26 p.m.)
Deposited	1 year, 11 months ago (Sept. 21, 2023, 11:41 a.m.)
Indexed	4 months, 3 weeks ago (April 8, 2025, 10:21 p.m.)
Issued	28 years, 5 months ago (March 15, 1997)
Published	28 years, 5 months ago (March 15, 1997)
Published Print	28 years, 5 months ago (March 15, 1997)

Funders 0

None

BibTeX

@article{Sing_1997, title={Isolation of Epstein-Barr Virus (EBV)-Specific Cytotoxic T Lymphocytes That Lyse Reed-Sternberg Cells: Implications for Immune-Mediated Therapy of EBV+ Hodgkin’s Disease}, volume={89}, ISSN={0006-4971}, url={http://dx.doi.org/10.1182/blood.v89.6.1978}, DOI={10.1182/blood.v89.6.1978}, number={6}, journal={Blood}, publisher={American Society of Hematology}, author={Sing, Amy P. and Ambinder, Richard F. and Hong, Doley J. and Jensen, Michael and Batten, Wendy and Petersdorf, Effie and Greenberg, Philip D.}, year={1997}, month=mar, pages={1978–1986} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2025,
        4,
        9
      ]
    ],
    "date-time": "2025-04-09T02:21:11Z",
    "timestamp": 1744165271749
  },
  "reference-count": 60,
  "publisher": "American Society of Hematology",
  "issue": "6",
  "content-domain": {
    "domain": [
      "ashpublications.org"
    ],
    "crossmark-restriction": true
  },
  "published-print": {
    "date-parts": [
      [
        1997,
        3,
        15
      ]
    ]
  },
  "abstract": "<jats:title>Abstract</jats:title><jats:p>A subset of Hodgkin's disease (HD) patients have detectable Epstein-Barr virus (EBV) genomes in the malignant Reed-Sternberg (R-S) cells. R-S cells express only a limited set of latent EBV proteins, but only LMP1 and LMP2 can potentially elicit a CD8+ cytotoxic T-lymphocyte (CTL) response. We have evaluated if either of these proteins could be used as targets for specific adoptive T-cell therapy for EBV-positive (EBV+) HD. The success of this strategy requires that R-S cells are susceptible to lysis by CD8+ CTL, and that CTL specific for LMP1 and LMP2 can be detected and potentially amplified in HD patients. Antigen presentation and CTL sensitivity was evaluated with an in vitro maintained, phenotypically representative R-S cell line, HDLM-2. The R-S cells were able to process and present viral proteins, and to be efficiently lysed by specific CTL in a Class I\u2013restricted manner. Since CTL responses to LMP1 and LMP2 do not represent the dominant responses to EBV, we examined if CTL clones specific for these proteins could be isolated despite the presence of weak or nondetectable responses in polyclonal T-cell lines. LMP-specific clones were generated from individuals either by cloning from the polyclonal EBV-reactive T-cell lines or by direct stimulation of peripheral blood mononuclear cells (PBMC) with cells expressing LMP1 or LMP2 as the only EBV protein. Our ability to isolate CTL specific for LMP proteins from individuals with HD and the sensitivity of R-S cells for CTL-mediated lysis suggest that the pursuit of specific adoptive immunotherapy represents a viable strategy for the subset of HD patients with EBV+ tumors.</jats:p>",
  "DOI": "10.1182/blood.v89.6.1978",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2019,
        10,
        12
      ]
    ],
    "date-time": "2019-10-12T19:26:45Z",
    "timestamp": 1570908405000
  },
  "page": "1978-1986",
  "update-policy": "http://dx.doi.org/10.1182/blood.2019cm0000",
  "source": "Crossref",
  "is-referenced-by-count": 90,
  "title": "Isolation of Epstein-Barr Virus (EBV)-Specific Cytotoxic T Lymphocytes That Lyse Reed-Sternberg Cells: Implications for Immune-Mediated Therapy of EBV+ Hodgkin's Disease",
  "prefix": "10.1182",
  "volume": "89",
  "author": [
    {
      "given": "Amy P.",
      "family": "Sing",
      "sequence": "first",
      "affiliation": [
        {
          "name": "From the Division of Oncology, University of Washington, Seattle; the Fred Hutchinson Cancer Research Center, Seattle, WA; and Johns Hopkins Medical Center, Baltimore, MD."
        }
      ]
    },
    {
      "given": "Richard F.",
      "family": "Ambinder",
      "sequence": "additional",
      "affiliation": [
        {
          "name": "From the Division of Oncology, University of Washington, Seattle; the Fred Hutchinson Cancer Research Center, Seattle, WA; and Johns Hopkins Medical Center, Baltimore, MD."
        }
      ]
    },
    {
      "given": "Doley J.",
      "family": "Hong",
      "sequence": "additional",
      "affiliation": [
        {
          "name": "From the Division of Oncology, University of Washington, Seattle; the Fred Hutchinson Cancer Research Center, Seattle, WA; and Johns Hopkins Medical Center, Baltimore, MD."
        }
      ]
    },
    {
      "given": "Michael",
      "family": "Jensen",
      "sequence": "additional",
      "affiliation": [
        {
          "name": "From the Division of Oncology, University of Washington, Seattle; the Fred Hutchinson Cancer Research Center, Seattle, WA; and Johns Hopkins Medical Center, Baltimore, MD."
        }
      ]
    },
    {
      "given": "Wendy",
      "family": "Batten",
      "sequence": "additional",
      "affiliation": [
        {
          "name": "From the Division of Oncology, University of Washington, Seattle; the Fred Hutchinson Cancer Research Center, Seattle, WA; and Johns Hopkins Medical Center, Baltimore, MD."
        }
      ]
    },
    {
      "given": "Effie",
      "family": "Petersdorf",
      "sequence": "additional",
      "affiliation": [
        {
          "name": "From the Division of Oncology, University of Washington, Seattle; the Fred Hutchinson Cancer Research Center, Seattle, WA; and Johns Hopkins Medical Center, Baltimore, MD."
        }
      ]
    },
    {
      "given": "Philip D.",
      "family": "Greenberg",
      "sequence": "additional",
      "affiliation": [
        {
          "name": "From the Division of Oncology, University of Washington, Seattle; the Fred Hutchinson Cancer Research Center, Seattle, WA; and Johns Hopkins Medical Center, Baltimore, MD."
        }
      ]
    }
  ],
  "member": "234",
  "reference": [
    {
      "key": "2019111909065557500_B1"
    },
    {
      "key": "2019111909065557500_B2",
      "doi-asserted-by": "crossref",
      "first-page": "17",
      "DOI": "10.1093/annonc/5.suppl_2.S17",
      "article-title": "The treatment of Hodgkin's disease.",
      "volume": "2",
      "author": "Rosenberg",
      "year": "1994",
      "journal-title": "Ann Oncol"
    },
    {
      "key": "2019111909065557500_B3",
      "doi-asserted-by": "crossref",
      "first-page": "47",
      "DOI": "10.1182/blood.V73.1.47.47",
      "article-title": "Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC Lymphoma Group Controlled Clinical Trials: 1964-1987.",
      "volume": "73",
      "author": "Tubiana",
      "year": "1989",
      "journal-title": "Blood"
    },
    {
      "key": "2019111909065557500_B4",
      "doi-asserted-by": "crossref",
      "first-page": "210",
      "DOI": "10.1200/JCO.1992.10.2.210",
      "article-title": "Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: The low probability for cure.",
      "volume": "10",
      "author": "Longo",
      "year": "1992",
      "journal-title": "J Clin Oncol"
    },
    {
      "key": "2019111909065557500_B5",
      "doi-asserted-by": "crossref",
      "first-page": "605",
      "DOI": "10.1016/0002-9343(91)90213-H",
      "article-title": "Autologous bone marrow transplantation for patients with relapsed Hodgkin's disease.",
      "volume": "91",
      "author": "Armitage",
      "year": "1991",
      "journal-title": "Am J Med"
    },
    {
      "key": "2019111909065557500_B6",
      "doi-asserted-by": "crossref",
      "first-page": "527",
      "DOI": "10.1200/JCO.1990.8.3.527",
      "article-title": "High-dose cytotoxic therapy and bone marrow transplantation for relapsed Hodgkin's disease.",
      "volume": "8",
      "author": "Jones",
      "year": "1990",
      "journal-title": "J Clin Oncol"
    },
    {
      "key": "2019111909065557500_B7",
      "doi-asserted-by": "crossref",
      "first-page": "238",
      "DOI": "10.1126/science.1352912",
      "article-title": "Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones.",
      "volume": "257",
      "author": "Riddell",
      "year": "1992",
      "journal-title": "Science"
    },
    {
      "key": "2019111909065557500_B8",
      "doi-asserted-by": "crossref",
      "first-page": "1038",
      "DOI": "10.1056/NEJM199510193331603",
      "article-title": "Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor.",
      "volume": "333",
      "author": "Walter",
      "year": "1995",
      "journal-title": "N Engl J Med"
    },
    {
      "key": "2019111909065557500_B9",
      "doi-asserted-by": "crossref",
      "first-page": "1643",
      "DOI": "10.1126/science.1840703",
      "article-title": "A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.",
      "volume": "254",
      "author": "van der Bruggen",
      "year": "1991",
      "journal-title": "Science"
    },
    {
      "key": "2019111909065557500_B10",
      "doi-asserted-by": "crossref",
      "first-page": "3515",
      "DOI": "10.1073/pnas.91.9.3515",
      "article-title": "Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor.",
      "volume": "91",
      "author": "Kawakami",
      "year": "1994",
      "journal-title": "Proc Natl Acad Sci USA"
    },
    {
      "key": "2019111909065557500_B11",
      "first-page": "321",
      "article-title": "Epidemiologic studies assessing the role of the Epstein-Barr virus in Hodgkin's disease.",
      "volume": "60",
      "author": "Mueller",
      "year": "1987",
      "journal-title": "Yale J Biol Med"
    },
    {
      "key": "2019111909065557500_B12",
      "first-page": "701",
      "article-title": "Epstein-Barr virus antibody in childhood Hodgkin's disease.",
      "volume": "136",
      "author": "Shope",
      "year": "1982",
      "journal-title": "Am J Dis Child"
    },
    {
      "key": "2019111909065557500_B13",
      "doi-asserted-by": "crossref",
      "first-page": "1183",
      "DOI": "10.1016/S0140-6736(81)92351-5",
      "article-title": "Presence of elevated antibody titres to Epstein-Barr virus before Hodgkin's disease.",
      "volume": "1",
      "author": "Evans",
      "year": "1981",
      "journal-title": "Lancet"
    },
    {
      "key": "2019111909065557500_B14",
      "doi-asserted-by": "crossref",
      "first-page": "1",
      "DOI": "10.1093/ajcp/91.1.1",
      "article-title": "A survey of Epstein-Barr virus DNA in lymphoid tissue. Frequent detection in Hodgkin's disease.",
      "volume": "91",
      "author": "Staal",
      "year": "1989",
      "journal-title": "Am J Clin Pathol"
    },
    {
      "key": "2019111909065557500_B15",
      "first-page": "1259",
      "article-title": "Epstein-Barr virus and Hodgkin's disease. A correlative in situ hybridization and polymerase chain reaction study.",
      "volume": "139",
      "author": "Weiss",
      "year": "1991",
      "journal-title": "Am J Pathol"
    },
    {
      "key": "2019111909065557500_B16",
      "doi-asserted-by": "crossref",
      "first-page": "801",
      "DOI": "10.1002/ijc.2910460509",
      "article-title": "Detection of EBV gene expression in Reed-Sternberg cells of Hodgkin's disease.",
      "volume": "46",
      "author": "Wu",
      "year": "1990",
      "journal-title": "Int J Cancer"
    },
    {
      "key": "2019111909065557500_B17",
      "first-page": "86",
      "article-title": "Epstein-Barr viral DNA in tissues of Hodgkin's disease.",
      "volume": "129",
      "author": "Weiss",
      "year": "1987",
      "journal-title": "Am J Pathol"
    },
    {
      "key": "2019111909065557500_B18",
      "doi-asserted-by": "crossref",
      "first-page": "4766",
      "DOI": "10.1073/pnas.88.11.4766",
      "article-title": "Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells.",
      "volume": "88",
      "author": "Herbst",
      "year": "1991",
      "journal-title": "Proc Natl Acad Sci USA"
    },
    {
      "key": "2019111909065557500_B19",
      "doi-asserted-by": "crossref",
      "first-page": "320",
      "DOI": "10.1016/0140-6736(91)90943-J",
      "article-title": "Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease.",
      "volume": "337",
      "author": "Pallesen",
      "year": "1991",
      "journal-title": "Lancet"
    },
    {
      "key": "2019111909065557500_B20",
      "doi-asserted-by": "crossref",
      "first-page": "339",
      "DOI": "10.1084/jem.177.2.339",
      "article-title": "Epstein-Barr virus and Hodgkin's disease: Transcriptional analysis of virus latency in the malignant cells.",
      "volume": "177",
      "author": "Deacon",
      "year": "1993",
      "journal-title": "J Exp Med"
    },
    {
      "key": "2019111909065557500_B21",
      "doi-asserted-by": "crossref",
      "first-page": "831",
      "DOI": "10.1016/0092-8674(85)90256-9",
      "article-title": "An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.",
      "volume": "43",
      "author": "Wang",
      "year": "1985",
      "journal-title": "Cell"
    },
    {
      "key": "2019111909065557500_B22",
      "doi-asserted-by": "crossref",
      "first-page": "2168",
      "DOI": "10.1128/JVI.69.4.2168-2174.1995",
      "article-title": "LMP-1 activates NF-kappa B by targeting the inhibitory molecule I kappa B alpha.",
      "volume": "69",
      "author": "Herrero",
      "year": "1995",
      "journal-title": "J Virol"
    },
    {
      "key": "2019111909065557500_B23",
      "first-page": "37",
      "article-title": "Absence of HLA class I expression by Reed-Sternberg cells.",
      "volume": "145",
      "author": "Poppema",
      "year": "1994",
      "journal-title": "Am J Pathol"
    },
    {
      "key": "2019111909065557500_B24",
      "doi-asserted-by": "crossref",
      "first-page": "2906",
      "DOI": "10.1073/pnas.87.8.2906",
      "article-title": "Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses.",
      "volume": "87",
      "author": "Murray",
      "year": "1990",
      "journal-title": "Proc Natl Acad Sci USA"
    },
    {
      "key": "2019111909065557500_B25",
      "doi-asserted-by": "crossref",
      "first-page": "157",
      "DOI": "10.1084/jem.176.1.157",
      "article-title": "Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): Implications for the immune control of EBV-positive malignancies.",
      "volume": "176",
      "author": "Murray",
      "year": "1992",
      "journal-title": "J Exp Med"
    },
    {
      "key": "2019111909065557500_B26",
      "doi-asserted-by": "crossref",
      "first-page": "1493",
      "DOI": "10.1182/blood.V86.4.1493.bloodjournal8641493",
      "article-title": "Local suppression of Epstein-Barr virus (EBV)-specific cytotoxicity in biopsies of EBV-positive Hodgkin's disease.",
      "volume": "86",
      "author": "Frisan",
      "year": "1995",
      "journal-title": "Blood"
    },
    {
      "key": "2019111909065557500_B27",
      "doi-asserted-by": "crossref",
      "first-page": "685",
      "DOI": "10.1038/375685a0",
      "article-title": "Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1.",
      "volume": "375",
      "author": "Levitskaya",
      "year": "1995",
      "journal-title": "Nature"
    },
    {
      "key": "2019111909065557500_B28",
      "doi-asserted-by": "crossref",
      "first-page": "75",
      "DOI": "10.1007/978-3-642-83781-4_8",
      "article-title": "Characterization of Hodgkin's disease derived cell line HDLM-2.",
      "volume": "117",
      "author": "Drexler",
      "year": "1989",
      "journal-title": "Recent Results Cancer Res"
    },
    {
      "key": "2019111909065557500_B29",
      "doi-asserted-by": "crossref",
      "first-page": "93",
      "DOI": "10.1111/j.1399-0039.1994.tb02364.x",
      "article-title": "Molecular diversity of the HLA-C locus in unrelated marrow transplantation.",
      "volume": "44",
      "author": "Petersdorf",
      "year": "1994",
      "journal-title": "Tissue Antigens"
    },
    {
      "key": "2019111909065557500_B30",
      "doi-asserted-by": "crossref",
      "first-page": "73",
      "DOI": "10.1111/j.1399-0039.1995.tb02482.x",
      "article-title": "A comprehensive approach for typing the alleles of the HLA-B locus by automated sequencing.",
      "volume": "46",
      "author": "Petersdorf",
      "year": "1995",
      "journal-title": "Tissue Antigens"
    },
    {
      "key": "2019111909065557500_B31",
      "doi-asserted-by": "crossref",
      "first-page": "1",
      "DOI": "10.1111/j.1399-0039.1995.tb02470.x",
      "article-title": "Nomenclature for factors of the HLA system, 1995.",
      "volume": "46",
      "author": "Bodmer",
      "year": "1995",
      "journal-title": "Tissue Antigens"
    },
    {
      "key": "2019111909065557500_B32"
    },
    {
      "key": "2019111909065557500_B33",
      "doi-asserted-by": "crossref",
      "first-page": "12",
      "DOI": "10.4049/jimmunol.135.1.12",
      "article-title": "Target specificity and cell surface structures involved in the human cytolytic T lymphocyte response to endothelial cells.",
      "volume": "135",
      "author": "Clayberger",
      "year": "1985",
      "journal-title": "J Immunol"
    },
    {
      "key": "2019111909065557500_B34",
      "doi-asserted-by": "crossref",
      "first-page": "581",
      "DOI": "10.1101/SQB.1989.054.01.069",
      "article-title": "Variation in HLA expression on tumors: An escape from immune response.",
      "volume": "1",
      "author": "Smith",
      "year": "1989",
      "journal-title": "Cold Spring Harb Symp Quant Biol"
    },
    {
      "key": "2019111909065557500_B35",
      "doi-asserted-by": "crossref",
      "first-page": "42",
      "DOI": "10.1111/j.1749-6632.1993.tb43994.x",
      "article-title": "Tumor escape from immune response by variation in HLA expression and other mechanisms.",
      "volume": "690",
      "author": "Bodmer",
      "year": "1993",
      "journal-title": "Ann NY Acad Sci"
    },
    {
      "key": "2019111909065557500_B36",
      "doi-asserted-by": "crossref",
      "first-page": "621",
      "DOI": "10.1084/jem.170.3.621",
      "article-title": "Suppression of class I human histocompatibility leukocyte antigen by c-myc is locus specific.",
      "volume": "170",
      "author": "Versteeg",
      "year": "1989",
      "journal-title": "J Exp Med"
    },
    {
      "key": "2019111909065557500_B37",
      "doi-asserted-by": "crossref",
      "first-page": "1205",
      "DOI": "10.1084/jem.179.4.1205",
      "article-title": "T cell costimulation by B7/BB1 induces CD8 T cell\u2013dependent tumor rejection: An important role of B7/BB1 in the induction, recruitment, and effector function of antitumor T cells.",
      "volume": "179",
      "author": "Ramarathinam",
      "year": "1994",
      "journal-title": "J Exp Med"
    },
    {
      "key": "2019111909065557500_B38",
      "doi-asserted-by": "crossref",
      "first-page": "216",
      "DOI": "10.1038/nm0296-216",
      "article-title": "T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients.",
      "volume": "2",
      "author": "Riddell",
      "year": "1996",
      "journal-title": "Nat Med"
    },
    {
      "key": "2019111909065557500_B39",
      "doi-asserted-by": "crossref",
      "first-page": "9",
      "DOI": "10.1016/S0140-6736(95)91150-2",
      "article-title": "Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus\u2013related lymphoproliferation.",
      "volume": "345",
      "author": "Rooney",
      "year": "1995",
      "journal-title": "Lancet"
    },
    {
      "key": "2019111909065557500_B40",
      "doi-asserted-by": "crossref",
      "first-page": "188",
      "DOI": "10.1002/ijc.2910470205",
      "article-title": "Expression of Epstein-Barr virus\u2013encoded growth-transformation\u2013associated proteins in lymphoproliferations of bone-marrow transplant recipients.",
      "volume": "47",
      "author": "Gratama",
      "year": "1991",
      "journal-title": "Int J Cancer"
    },
    {
      "key": "2019111909065557500_B41",
      "doi-asserted-by": "crossref",
      "first-page": "400",
      "DOI": "10.1007/BF02634361",
      "article-title": "Morphologic and immunophenotypic characterization of a cell line derived from liver tissue with Epstein-Barr virus associated post-transplant lymphoproliferative disease.",
      "volume": "6",
      "author": "Randhawa",
      "year": "1994",
      "journal-title": "In Vitro Cell Dev Biol Anim"
    },
    {
      "key": "2019111909065557500_B42",
      "doi-asserted-by": "crossref",
      "first-page": "147",
      "DOI": "10.1084/jem.173.1.147",
      "article-title": "Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: Implications for the pathogenesis of EBV-positive lymphomas in man.",
      "volume": "173",
      "author": "Rowe",
      "year": "1991",
      "journal-title": "J Exp Med"
    },
    {
      "key": "2019111909065557500_B43",
      "first-page": "504",
      "article-title": "Expression of Epstein-Barr virus nuclear antigens in anti-IgM\u2013stimulated B cells following recombinant vaccinia infection and their recognition by human cytotoxic T cells.",
      "volume": "74",
      "author": "Khanna",
      "year": "1991",
      "journal-title": "Immunology"
    },
    {
      "key": "2019111909065557500_B44",
      "first-page": "4",
      "article-title": "Potential antigenic targets on Epstein-Barr virus\u2013associated tumours and the host response.",
      "volume": "187",
      "author": "Moss",
      "year": "1994",
      "journal-title": "Ciba Found Symp"
    },
    {
      "key": "2019111909065557500_B45",
      "first-page": "345",
      "article-title": "Hodgkin's disease cell lines: A model for interleukin-1\u2013independent accessory cell function [published erratum appears in Immunology 77:628, 1992].",
      "volume": "77",
      "author": "McKenzie",
      "year": "1992",
      "journal-title": "Immunology"
    },
    {
      "key": "2019111909065557500_B46",
      "doi-asserted-by": "crossref",
      "first-page": "4567",
      "DOI": "10.1073/pnas.84.13.4567",
      "article-title": "Down-regulation of class I HLA antigens and of the Epstein-Barr virus\u2013encoded latent membrane protein in Burkitt lymphoma lines.",
      "volume": "84",
      "author": "Masucci",
      "year": "1987",
      "journal-title": "Proc Natl Acad Sci USA"
    },
    {
      "key": "2019111909065557500_B47",
      "doi-asserted-by": "crossref",
      "first-page": "1283",
      "DOI": "10.1093/intimm/4.11.1283",
      "article-title": "Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: In vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.",
      "volume": "4",
      "author": "Masucci",
      "year": "1992",
      "journal-title": "Int Immunol"
    },
    {
      "key": "2019111909065557500_B48",
      "doi-asserted-by": "crossref",
      "first-page": "5154",
      "DOI": "10.4049/jimmunol.150.11.5154",
      "article-title": "EBV peptide epitope sensitization restores human cytotoxic T cell recognition of Burkitt's lymphoma cells. Evidence for a critical role for ICAM-2.",
      "volume": "150",
      "author": "Khanna",
      "year": "1993",
      "journal-title": "J Immunol"
    },
    {
      "key": "2019111909065557500_B49",
      "doi-asserted-by": "crossref",
      "first-page": "1811",
      "DOI": "10.1084/jem.167.6.1811",
      "article-title": "Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus\u2013positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance.",
      "volume": "167",
      "author": "Gregory",
      "year": "1988",
      "journal-title": "J Exp Med"
    },
    {
      "key": "2019111909065557500_B50",
      "doi-asserted-by": "crossref",
      "first-page": "3844",
      "DOI": "10.1182/blood.V87.9.3844.bloodjournal8793844",
      "article-title": "Analysis of major histocompatibility complex class I expression on Reed-Sternberg cells in relation to the cytotoxic T-cell response in Epstein-Barr virus\u2013positive and \u2013negative Hodgkin's disease.",
      "volume": "87",
      "author": "Oudejans",
      "year": "1996",
      "journal-title": "Blood"
    },
    {
      "key": "2019111909065557500_B51",
      "doi-asserted-by": "crossref",
      "first-page": "725",
      "DOI": "10.1016/0046-8177(93)90008-5",
      "article-title": "Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin's disease and non-Hodgkin's lymphomas arising in patients without overt pre-existing immunodeficiency.",
      "volume": "24",
      "author": "Kanavaros",
      "year": "1993",
      "journal-title": "Hum Pathol"
    },
    {
      "key": "2019111909065557500_B52",
      "doi-asserted-by": "crossref",
      "first-page": "185",
      "DOI": "10.1016/B978-0-12-364933-1.50013-8",
      "article-title": "Hodgkin's disease: Analysis of cell line data.",
      "volume": "33",
      "author": "von-Kalle",
      "year": "1992",
      "journal-title": "Int Rev Exp Pathol"
    },
    {
      "key": "2019111909065557500_B53",
      "doi-asserted-by": "crossref",
      "first-page": "265",
      "DOI": "10.1084/jem.177.2.265",
      "article-title": "Identification of human cancers deficient in antigen processing.",
      "volume": "177",
      "author": "Restifo",
      "year": "1993",
      "journal-title": "J Exp Med"
    },
    {
      "key": "2019111909065557500_B54",
      "doi-asserted-by": "crossref",
      "first-page": "264",
      "DOI": "10.1007/BF02918734",
      "article-title": "Tumor growth and evasion of immune destruction: UV-induced tumors as a model.",
      "volume": "4",
      "author": "Mullen",
      "year": "1985",
      "journal-title": "Surv Immunol Res"
    },
    {
      "key": "2019111909065557500_B55",
      "doi-asserted-by": "crossref",
      "first-page": "933",
      "DOI": "10.1084/jem.178.3.933",
      "article-title": "A tumor escape variant that has lost one major histocompatibility complex class I restriction element induces specific CD8+ T cells to an antigen that no longer serves as a target.",
      "volume": "178",
      "author": "Seung",
      "year": "1993",
      "journal-title": "J Exp Med"
    },
    {
      "key": "2019111909065557500_B56",
      "doi-asserted-by": "crossref",
      "first-page": "1795",
      "DOI": "10.1126/science.1465616",
      "article-title": "Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice.",
      "volume": "258",
      "author": "Mizoguchi",
      "year": "1992",
      "journal-title": "Science"
    },
    {
      "key": "2019111909065557500_B57",
      "doi-asserted-by": "crossref",
      "first-page": "236",
      "DOI": "10.1182/blood.V88.1.236.236",
      "article-title": "T cells from patients with Hodgkin's disease have a defective T-cell receptor zeta chain expression that is reversible by T-cell stimulation with CD3 and CD28.",
      "volume": "88",
      "author": "Renner",
      "year": "1996",
      "journal-title": "Blood"
    },
    {
      "key": "2019111909065557500_B58",
      "first-page": "1327",
      "article-title": "Alterations in T cell receptor and signal transduction molecules in melanoma patients.",
      "volume": "1",
      "author": "Zea",
      "year": "1995",
      "journal-title": "Clin Cancer Res"
    },
    {
      "key": "2019111909065557500_B59",
      "doi-asserted-by": "crossref",
      "first-page": "2918",
      "DOI": "10.1182/blood.V87.7.2918.bloodjournal8772918",
      "article-title": "Frequent expression of interleukin-10 by Epstein-Barr virus\u2013harboring tumor cells of Hodgkin's disease.",
      "volume": "87",
      "author": "Herbst",
      "year": "1996",
      "journal-title": "Blood"
    },
    {
      "key": "2019111909065557500_B60",
      "doi-asserted-by": "crossref",
      "first-page": "1770",
      "DOI": "10.4049/jimmunol.129.4.1770",
      "article-title": "Depressed T cell proliferative responses in Hodgkin's disease: Role of monocyte-mediated suppression via prostaglandins and hydrogen peroxide.",
      "volume": "129",
      "author": "Fisher",
      "year": "1982",
      "journal-title": "J Immunol"
    }
  ],
  "container-title": "Blood",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "http://ashpublications.org/blood/article-pdf/89/6/1978/1409881/1978.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "syndication"
    },
    {
      "URL": "http://ashpublications.org/blood/article-pdf/89/6/1978/1409881/1978.pdf",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2023,
        9,
        21
      ]
    ],
    "date-time": "2023-09-21T15:41:50Z",
    "timestamp": 1695310910000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "https://ashpublications.org/blood/article/89/6/1978/139096/Isolation-of-EpsteinBarr-Virus-EBVSpecific"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        1997,
        3,
        15
      ]
    ]
  },
  "references-count": 60,
  "journal-issue": {
    "issue": "6",
    "published-print": {
      "date-parts": [
        [
          1997,
          3,
          15
        ]
      ]
    }
  },
  "URL": "http://dx.doi.org/10.1182/blood.V89.6.1978",
  "relation": {},
  "ISSN": [
    "1528-0020",
    "0006-4971"
  ],
  "subject": [],
  "published": {
    "date-parts": [
      [
        1997,
        3,
        15
      ]
    ]
  }
}